Results 171 to 180 of about 172,250 (212)
Some of the next articles are maybe not open access.
Revista Española de Anestesiología y Reanimación (English Edition), 2021
M, Basora Macaya +2 more
openaire +2 more sources
M, Basora Macaya +2 more
openaire +2 more sources
Hydroxyethyl starch: A half‐century enigma
Acta Anaesthesiologica Scandinavica, 2018HES history HES was introduced in clinical practice in the 1960s, since then concerns on its safety and efficacy have been consistently and extensively raised (0, 1, 14b). As early as in 1968, it was reported abnormal massive bleeding in patients that received HES and Authors commented: “(...)there is need for further investigation (...)in patients ...
Bilotta, Federico +3 more
openaire +2 more sources
Annales francaises d'anesthesie et de reanimation, 2010
The purpose of this review is to draw up a statement on current knowledge available on the more recent hydroxyethyl starch (HES).References were obtained from computerized bibliographic research (Medline), recent review articles, the library of the service and personal files.All categories of articles on this topic have been selected.Articles have been
F, Wierre +3 more
openaire +1 more source
The purpose of this review is to draw up a statement on current knowledge available on the more recent hydroxyethyl starch (HES).References were obtained from computerized bibliographic research (Medline), recent review articles, the library of the service and personal files.All categories of articles on this topic have been selected.Articles have been
F, Wierre +3 more
openaire +1 more source
Hydroxyethyl starch and coagulation
1999Hydroxyethyl starch (HES) is one of the most frequently used volume replacement agents. Its advantages, such as high efficacy, few allergic reactions, low cost and general availability, are generally acknowledged. The main disadvantage of HES is its adverse effects on coagulation and resulting hemorrhagic complications.
J. Treib, M. T. Grauer
openaire +1 more source
The Pros and Cons of Hydroxyethyl Starch Solutions
Anesthesia & Analgesia, 2007info:eu-repo/semantics ...
openaire +4 more sources
Developments in biological standardization, 1978
HES products should be designated by both their number average of molecular weight (that determines colloidal activity) and molar substitution ratios. In addition to the original HES-70/70 developed in 1960, a rapidly excreted HES-50/50 has been available since 1977.
openaire +2 more sources
HES products should be designated by both their number average of molecular weight (that determines colloidal activity) and molar substitution ratios. In addition to the original HES-70/70 developed in 1960, a rapidly excreted HES-50/50 has been available since 1977.
openaire +2 more sources
Hydroxyethyl starch and blood coagulation
European Journal of Anaesthesiology, 1999M, Booke +4 more
openaire +2 more sources